MELISSA RADUAZZO: Open Payments
NPI 1497113856 · NISKAYUNA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 39 payments from 11 companies in 2025. Trend: 2023 $434 · 2024 $552 · 2025 $862
Food & beverage: $675Education: $187
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $245 |
| Lilly USA, LLC | 2 | $137 |
| Axsome Therapeutics, Inc. | 7 | $128 |
| HARMONY BIOSCIENCES LLC | 3 | $99 |
| Astellas Pharma US Inc | 1 | $79 |
| JAZZ PHARMACEUTICALS INC. | 3 | $75 |
| Electromed, Inc. | 2 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Verona Pharma, Inc. | 1 | $17 |
Products named: NUCALA, ZEPBOUND, Sunosi, XYWAV, WAKIX, SMARTVEST, UPTRAVI, BREZTRI.
Industry payments across NY — which companies pay providers there.
